A detailed history of Nisa Investment Advisors, LLC transactions in Staar Surgical CO stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 489 shares of STAA stock, worth $21,970. This represents 0.0% of its overall portfolio holdings.

Number of Shares
489
Previous 445 9.89%
Holding current value
$21,970
Previous $13,000 38.46%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$27.67 - $39.61 $1,217 - $1,742
44 Added 9.89%
489 $18,000
Q4 2023

Jan 25, 2024

SELL
$30.6 - $43.78 $61,200 - $87,560
-2,000 Reduced 81.8%
445 $13,000
Q3 2023

Nov 02, 2023

BUY
$39.39 - $58.12 $77,637 - $114,554
1,971 Added 415.82%
2,445 $98,000
Q2 2023

Aug 11, 2023

SELL
$50.45 - $72.82 $128,193 - $185,035
-2,541 Reduced 84.28%
474 $24,000
Q1 2023

May 02, 2023

BUY
$51.25 - $79.34 $80,975 - $125,357
1,580 Added 110.1%
3,015 $193,000
Q4 2022

Feb 02, 2023

SELL
$46.82 - $76.2 $4,120 - $6,705
-88 Reduced 5.78%
1,435 $70,000
Q3 2022

Nov 07, 2022

BUY
$70.55 - $111.58 $7,831 - $12,385
111 Added 7.86%
1,523 $108,000
Q2 2022

Aug 03, 2022

SELL
$50.24 - $80.48 $1,406 - $2,253
-28 Reduced 1.94%
1,412 $100,000
Q1 2022

Apr 29, 2022

SELL
$57.98 - $93.5 $5,218 - $8,415
-90 Reduced 5.88%
1,440 $115,000
Q4 2021

Feb 03, 2022

SELL
$88.02 - $127.79 $23,765 - $34,503
-270 Reduced 15.0%
1,530 $111,000
Q2 2021

Aug 06, 2021

SELL
$105.76 - $154.96 $5,288 - $7,748
-50 Reduced 2.7%
1,800 $275,000
Q4 2020

Jan 25, 2021

BUY
$55.93 - $82.78 $39,151 - $57,946
700 Added 60.87%
1,850 $147,000
Q3 2020

Oct 20, 2020

BUY
$45.65 - $61.81 $52,497 - $71,081
1,150 New
1,150 $65,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $2.16B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.